Oppenheimer & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33M | Buy |
|
|||||
|
2025
Q1 | $32.5M | Buy |
|
|||||
|
2024
Q4 | $26.4M | Buy |
|
|||||
|
2024
Q3 | $23.9M | Sell |
|
|||||
|
2024
Q2 | $19.8M | Sell |
|
|||||
|
2024
Q1 | $21.7M | Sell |
|
|||||
|
2023
Q4 | $24.2M | Sell |
|
|||||
|
2023
Q3 | $24.9M | Sell |
|
|||||
|
2023
Q2 | $26.2M | Sell |
|
|||||
|
2023
Q1 | $28.9M | Sell |
|
|||||
|
2022
Q4 | $30.2M | Sell |
|
|||||
|
2022
Q3 | $25.8M | Buy |
|
|||||
|
2022
Q2 | $24.3M | Sell |
|
|||||
|
2022
Q1 | $23.7M | Sell |
|
|||||
|
2021
Q4 | $31.2M | Sell |
|
|||||
|
2021
Q3 | $31.6M | Buy |
|
|||||
|
2021
Q2 | $28.7M | Buy |
|
|||||
|
2021
Q1 | $22.7M | Buy |
|
|||||
|
2020
Q4 | $19.8M | Sell |
|
|||||
|
2020
Q3 | $24.7M | Sell |
|
|||||
|
2020
Q2 | $30.6M | Sell |
|
|||||
|
2020
Q1 | $32.3M | Buy |
|
|||||
|
2019
Q4 | $24.7M | Sell |
|
|||||
|
2019
Q3 | $24.4M | Sell |
|
|||||
|
2019
Q2 | $26.7M | Sell |
|
|||||
|
2019
Q1 | $25.8M | Sell |
|
|||||
|
2018
Q4 | $25.8M | Sell |
|
|||||
|
2018
Q3 | $32.1M | Buy |
|
|||||
|
2018
Q2 | $29.3M | Sell |
|
|||||
|
2018
Q1 | $76.5M | Buy |
|
|||||
|
2017
Q4 | $71.8M | Sell |
|
|||||
|
2017
Q3 | $81.4M | Sell |
|
|||||
|
2017
Q2 | $72.6M | Buy |
|
|||||
|
2017
Q1 | $69.1M | Sell |
|
|||||
|
2016
Q4 | $76.1M | Sell |
|
|||||
|
2016
Q3 | $88.4M | Sell |
|
|||||
|
2016
Q2 | $97.8M | Sell |
|
|||||
|
2016
Q1 | $109M | Sell |
|
|||||
|
2015
Q4 | $121M | Buy |
|
|||||
|
2015
Q3 | $115M | Buy |
|
|||||
|
2015
Q2 | $121M | Buy |
|
|||||
|
2015
Q1 | $54.1M | Buy |
|
|||||
|
2014
Q4 | $51.2M | Sell |
|
|||||
|
2014
Q3 | $59.1M | Sell |
|
|||||
|
2014
Q2 | $47.4M | Buy |
|
|||||
|
2014
Q1 | $38.9M | Buy |
|
|||||
|
2013
Q4 | $40.3M | Buy |
|
|||||
|
2013
Q3 | $32.8M | Buy |
|
|||||
|
2013
Q2 | $24.8M | Buy |
|